[IE-01] International Education Course 01「Glamping with PD experts across the world」

[IE-01-3] Looking to the future: disease-modifying therapies for Parkinson's disease

Lorraine V. Kalia (University of Toronto, Canada)

Dr. Lorraine Kalia is a clinician-scientist at the University of Toronto in Toronto, Canada. Her clinical practice and research program focus on Parkinson’s disease and related neurodegenerative disorders. She received her initial training in the MD/PhD program and the adult neurology residency program at the University of Toronto. She conducted a postdoctoral research fellowship at Massachusetts General Hospital and then a movement disorders fellowship at Toronto Western Hospital. Currently, she is an associate professor in the Division of Neurology at the University of Toronto and a senior scientist in the Krembil Research Institute at University Health Network. She is also a staff neurologist in the Movement Disorders Clinic at Toronto Western Hospital. She holds the Wolfond-Krembil Chair in Parkinson's Disease Research and leads a research program aimed at understanding the key molecular mechanisms responsible for neurodegeneration to identify much needed disease-modifying therapies for Parkinson's disease.